» Articles » PMID: 22745809

Principal Component Analysis of the Cytokine and Chemokine Response to Human Traumatic Brain Injury

Overview
Journal PLoS One
Date 2012 Jun 30
PMID 22745809
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

There is a growing realisation that neuro-inflammation plays a fundamental role in the pathology of Traumatic Brain Injury (TBI). This has led to the search for biomarkers that reflect these underlying inflammatory processes using techniques such as cerebral microdialysis. The interpretation of such biomarker data has been limited by the statistical methods used. When analysing data of this sort the multiple putative interactions between mediators need to be considered as well as the timing of production and high degree of statistical co-variance in levels of these mediators. Here we present a cytokine and chemokine dataset from human brain following human traumatic brain injury and use principal component analysis and partial least squares discriminant analysis to demonstrate the pattern of production following TBI, distinct phases of the humoral inflammatory response and the differing patterns of response in brain and in peripheral blood. This technique has the added advantage of making no assumptions about the Relative Recovery (RR) of microdialysis derived parameters. Taken together these techniques can be used in complex microdialysis datasets to summarise the data succinctly and generate hypotheses for future study.

Citing Articles

Deciphering Proteomic Expression in Inflammatory Disorders: A Mass Spectrometry Exploration Comparing Infectious, Noninfectious, and Traumatic Brain Injuries in Human Cerebrospinal Fluid.

Dyhrfort P, Lindblad C, Widgren A, Virhammar J, Piehl F, Bergquist J Neurotrauma Rep. 2024; 5(1):857-873.

PMID: 39391051 PMC: 11462427. DOI: 10.1089/neur.2024.0050.


The contribution of the meningeal immune interface to neuroinflammation in traumatic brain injury.

Mokbel A, Burns M, Main B J Neuroinflammation. 2024; 21(1):135.

PMID: 38802931 PMC: 11131220. DOI: 10.1186/s12974-024-03122-7.


Connecting cellular mechanisms and extracellular vesicle cargo in traumatic brain injury.

Ollen-Bittle N, Roseborough A, Wang W, Wu J, Whitehead S Neural Regen Res. 2024; 19(10):2119-2131.

PMID: 38488547 PMC: 11034607. DOI: 10.4103/1673-5374.391329.


Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury.

Lindblad C, Rostami E, Helmy A Neurotherapeutics. 2023; 20(6):1508-1528.

PMID: 37610701 PMC: 10684479. DOI: 10.1007/s13311-023-01421-0.


and post-natal opioid exposure followed by mild traumatic brain injury contributes to cortical neuroinflammation, mitochondrial dysfunction, and behavioral deficits in juvenile rats.

Gowen A, Yi J, Stauch K, Miles L, Srinivasan S, Odegaard K Brain Behav Immun Health. 2023; 32:100669.

PMID: 37588011 PMC: 10425912. DOI: 10.1016/j.bbih.2023.100669.


References
1.
Helmy A, Timofeev I, Palmer C, Gore A, Menon D, Hutchinson P . Hierarchical log linear analysis of admission blood parameters and clinical outcome following traumatic brain injury. Acta Neurochir (Wien). 2010; 152(6):953-7. DOI: 10.1007/s00701-009-0584-y. View

2.
Pinteaux E, Trotter P, Simi A . Cell-specific and concentration-dependent actions of interleukin-1 in acute brain inflammation. Cytokine. 2008; 45(1):1-7. DOI: 10.1016/j.cyto.2008.10.008. View

3.
Mosser D, Edwards J . Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8(12):958-69. PMC: 2724991. DOI: 10.1038/nri2448. View

4.
Pleines U, Morganti-Kossmann M, Rancan M, Joller H, Trentz O, Kossmann T . S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma. 2001; 18(5):491-8. DOI: 10.1089/089771501300227297. View

5.
Semple B, Frugier T, Morganti-Kossmann M . CCL2 modulates cytokine production in cultured mouse astrocytes. J Neuroinflammation. 2010; 7:67. PMC: 2964657. DOI: 10.1186/1742-2094-7-67. View